DE60116474D1 - Hcv ns2/3 fragmente und ihre verwendungen - Google Patents

Hcv ns2/3 fragmente und ihre verwendungen

Info

Publication number
DE60116474D1
DE60116474D1 DE60116474T DE60116474T DE60116474D1 DE 60116474 D1 DE60116474 D1 DE 60116474D1 DE 60116474 T DE60116474 T DE 60116474T DE 60116474 T DE60116474 T DE 60116474T DE 60116474 D1 DE60116474 D1 DE 60116474D1
Authority
DE
Germany
Prior art keywords
hcv
fragments
renatured
modulators
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60116474T
Other languages
English (en)
Other versions
DE60116474T2 (de
Inventor
Irbm P Angeletti Steinkuhler
Irbm P Angeletti Pallaoro
Ist Ric Biol Molecolare P Lahm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Publication of DE60116474D1 publication Critical patent/DE60116474D1/de
Application granted granted Critical
Publication of DE60116474T2 publication Critical patent/DE60116474T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Hydrogenated Pyridines (AREA)
  • Detergent Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60116474T 2000-03-17 2001-03-14 Hcv ns2/3 fragmente und ihre verwendungen Expired - Fee Related DE60116474T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0006537.5A GB0006537D0 (en) 2000-03-17 2000-03-17 Assays and screening methods
GB0006537 2000-03-17
PCT/IB2001/000527 WO2001068818A2 (en) 2000-03-17 2001-03-14 Hcv ns2/3 fragments and uses thereof

Publications (2)

Publication Number Publication Date
DE60116474D1 true DE60116474D1 (de) 2006-03-30
DE60116474T2 DE60116474T2 (de) 2006-09-07

Family

ID=9887885

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60116474T Expired - Fee Related DE60116474T2 (de) 2000-03-17 2001-03-14 Hcv ns2/3 fragmente und ihre verwendungen

Country Status (10)

Country Link
US (1) US7078215B2 (de)
EP (1) EP1278867B1 (de)
JP (1) JP2003526361A (de)
AT (1) ATE315093T1 (de)
AU (1) AU4269401A (de)
CA (1) CA2403405A1 (de)
DE (1) DE60116474T2 (de)
ES (1) ES2254380T3 (de)
GB (1) GB0006537D0 (de)
WO (1) WO2001068818A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0302558A3 (en) * 2000-12-15 2012-03-28 Boehringer Ingelheim Ca Ltd Purified active hcv ns2/3 protease
DE60304435T2 (de) * 2004-01-19 2006-08-24 Ares Trading S.A. Verfahren zur Reinigung von in Bakterien exprimierten Proteinen
US20090233266A1 (en) * 2005-03-10 2009-09-17 The Rockefeller University Structure of the hepatitis c virus ns2 protein
EP1945797B1 (de) * 2005-10-28 2012-05-30 Boehringer Ingelheim International GmbH Hepatitis-c-virus-ns2/3-aktivitätstest
EP2388312A1 (de) 2010-05-17 2011-11-23 Curetis AG Universell anwendbarer Lysepuffer und Verarbeitungsverfahren zur Lyse von Körperproben

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
IT1277914B1 (it) * 1995-08-22 1997-11-12 Angeletti P Ist Richerche Bio Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
WO2001016379A1 (en) * 1999-08-30 2001-03-08 Merck & Co., Inc. Hepatitis c virus replication inhibitors
HUP0302558A3 (en) * 2000-12-15 2012-03-28 Boehringer Ingelheim Ca Ltd Purified active hcv ns2/3 protease

Also Published As

Publication number Publication date
ATE315093T1 (de) 2006-02-15
WO2001068818A3 (en) 2002-03-21
GB0006537D0 (en) 2000-05-10
CA2403405A1 (en) 2001-09-20
JP2003526361A (ja) 2003-09-09
EP1278867A2 (de) 2003-01-29
DE60116474T2 (de) 2006-09-07
US7078215B2 (en) 2006-07-18
WO2001068818A2 (en) 2001-09-20
AU4269401A (en) 2001-09-24
EP1278867B1 (de) 2006-01-04
ES2254380T3 (es) 2006-06-16
US20040054134A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
ATE212037T1 (de) Inhibitoren von serinproteasen, insbesondere von ns3-protease des hepatitis-c-virus
DK1268847T3 (da) Ubiquitin-ligaseassay
ATE421973T1 (de) Inzektizide proteinen von bacillus thuringiensis
DE60111534D1 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
ATE294867T1 (de) Mutierte alpha-amylase aus bacillus licheniformis,die eine modifizierung von resten a210, h405 und/oder t412 enthält
DE60326259D1 (de) Neue fructosylpeptidoxidase und deren nutzung
IT1272179B (it) Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
ATE500323T1 (de) Subtilisin-variante
DE69842027D1 (de) Mutanten der alpha-amylase
ATE259512T1 (de) Tragbares telefon und einschaltverfahren
NO20053595L (no) Escitalopramdibromid samt fremgangsmate ved fremstilling derav.
NO20015785L (no) I dets vesentlige oljefrie cyklosporinblandinger
DE60219068D1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
ATE426603T1 (de) Acyl- und sulfonylderivative 6,9- disubstitutierter 2-(trans-1,4-diaminocyclohexyl)-purine und ihre verwendung als antiproliferative mittel
ID30417A (id) Popok sekali pakai dan proses pembuatannya
DE60009888D1 (de) Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
ATE267867T1 (de) Chimäre serinproteasen
NO20031860L (no) Kahalalid F
ITRM950573A0 (it) Procedimento per produrre - in forma pura ed in quantita' elevate- polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e metodologia per riprodurre e saggiare efficacemente in vitro l'attivi-ta' proteolitica dei suddetti polipeptidi
DE60116474D1 (de) Hcv ns2/3 fragmente und ihre verwendungen
WO2006024020A3 (en) Hcv non-structural protein mutants and uses thereof
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
BR0213278B1 (pt) composição vedante e seu uso.
DE60201337D1 (de) Kontinuierliche umesterung von alkoxysilanen
ATE326520T1 (de) Teilchen für flüssige zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee